secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001193125-25-137478
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences appoints Bernd Brust as CEO, succeeding William Martin
---------------------------------------------------------------------------

- Bernd Brust named CEO and board member effective June 8, 2025; William Martin resigned as CEO and from board.
- Brust's base salary is $750,000 with a target annual cash bonus of 100% of base salary.
- Equity awards: 1M stock options, 2M RSUs, 2.25M PSUs; options and RSUs vest over three years.
- Martin's departure not due to any disagreement; he is eligible for severance per existing agreement.
- Company will revisit FY2025 guidance in August Q2 earnings call after Brust's assessment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000119312525137478/0001193125-25-137478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000119312525137478/d94141d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer